3:10 PM
May 20, 2019
 |  BC Extra  |  Politics & Policy

Community Oncology Alliance pushing alternative to pricing index for Part B drugs

The Community Oncology Alliance is in discussions with congressional staff and the Trump administration about modifying the existing Medicare Part B payment structure as an alternative to the International Pricing Index that HHS Secretary Alex Azar has proposed for Part B drugs.

In comments submitted to CMS in December 2018, COA, a politically potent organization that represents community oncology practices, suggested the establishment of a “tiered structure for brands whereby higher priced brands have a lower...

Read the full 369 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >